Palbociclib and cetuximab in cetuximab-resistant human papillomavirus-related oropharynx squamous-cell carcinoma: A multicenter phase 2 trial
Peter Oppelt, Jessica Ley, Francis P. Worden, Kevin Palka, Ronald J. Maggiore, Jingxia Liu, Douglas R. Adkins
Topics & Concepts
CetuximabMedicineInternal medicinePalbociclibOncologyClinical endpointHead and neck squamous-cell carcinomaRegimenPhases of clinical researchHead and neck cancerClinical trialCancerColorectal cancerBreast cancerMetastatic breast cancerAdvanced Breast Cancer TherapiesHead and Neck Cancer StudiesCancer-related Molecular Pathways